Haifeng Li, Xu Zhang. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralCladribine/therapeutic useDisability EvaluationDisease ProgressionHumansImmunosuppressive Agents/therapeutic useMultiple Sclerosis, Relapsing-Remitting/drug therapy
Substances: See more » Immunosuppressive AgentsCladribine
Year: 2010 PMID: 20449878
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245